Create account

Coverage dated March 20, 2025

AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe

Headline from NBC New York

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the Chinese capital.

NBC New York's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

6 articles, oldest first.

  1. NBC New York

    AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe (opens NBC New York)

    Published

    NBC New York's feed description

    British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the Chinese capital.

  2. UPI

    AstraZeneca to build $2.5B research hub in Beijing (opens UPI)

    Published

    UPI's feed description

    AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday.

  3. The Guardian

    AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing (opens The Guardian)

    Published

    The Guardian's feed description

    Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe | Since Then